Chiral Quest, a Subsidiary of VioQuest Pharmaceuticals, to Host First Annual Process Research Technology Conference
08 mars 2006 09h33 HE
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., March 8, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) subsidiary Chiral Quest is hosting the first annual Process Research Technology Conference, an...
VioQuest Pharmaceuticals Named One of Deloitte's 500 Fastest Growing North American Technology Companies
15 févr. 2006 08h30 HE
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Feb. 15, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) was named among the "2005 Deloitte Technology Fast 500," a collection of the 500 fastest growing...
VioQuest's Targeted Cancer Therapeutics Featured in 'Healthwatch' On New Jersey Public Television and Other Television Stations Across the Country
23 janv. 2006 09h25 HE
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Jan. 23, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals (OTCBB:VQPH), a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing targeted...
VioQuest Pharmaceuticals Highlights 2005 Achievements
10 janv. 2006 08h00 HE
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Jan. 10, 2006 (PRIMEZONE) -- During 2005 VioQuest Pharmaceuticals (OTCBB:VQPH) made significant progress on its business strategy and achieved several important...
VioQuest Pharmaceuticals Announces Clinical Trials to Begin in First Quarter 2006 for VQD-002, a Targeted Akt/Anti-Cancer Therapeutic
09 janv. 2006 08h30 HE
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Jan. 9, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals (OTCBB:VQPH) has announced that it will initiate clinical trials in the first quarter 2006, for VQD-002,...
VioQuest Pharmaceuticals to Receive Approximately $500,000 of Non-Dilutive Funds through Agreement with New Jersey Economic Development Authority
13 déc. 2005 08h00 HE
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Dec. 13, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals (OTCBB:VQPH) will receive approximately $500,000 from the sale of its Net Operating Losses (NOLs) pursuant to an...
VioQuest Appoints Dr. Johnson Lau to Board of Directors
02 déc. 2005 08h32 HE
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Dec. 2, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc., (OTCBB:VQPH) has named Johnson Y.N. Lau, M.B., B.S., M.D., F.R.C.P., to the Company's Board of Directors.
Dr....
VioQuest Pharmaceuticals to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference
02 nov. 2005 08h00 HE
|
VioQuest Pharmaceuticals
MONMOUTH, N.J., Nov. 2, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc., (OTCBB:VQPH) has accepted an invitation to present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference at...
VioQuest Pharmaceuticals to Present at 2005 Medical Innovation Summit Hosted by Cleveland Clinic
24 oct. 2005 08h00 HE
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Oct. 24, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) has accepted an invitation to present at the 2005 Medical Innovation Summit: Bench to Bedside and...
VioQuest Pharmaceuticals to Present at PIPEs Conference 2005 in New York City
21 oct. 2005 08h00 HE
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Oct. 21, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) has accepted an invitation to present at the 3rd Annual PIPEs Conference 2005 on October 26 and 27 at...